Bharat Biotech, GSK to cut malaria vaccine price by more than half by 2028

Hyderabad: Bharat Biotech, GSK to halve malaria vaccine price

Hyderabad: Hyderabad based vaccine manufacturer Bharat Biotech International Limited (BBIL) and global pharma major GSK have jointly pledged support to Gavi, the Vaccine Alliance, in accelerating the rollout of the world’s first malaria vaccine, RTS,S. As part of their commitment, Bharat Biotech announced that the price of the RTS,S vaccine will be reduced by more than half to under $5 per dose by 2028. This major price drop is made possible thr…

Bharat Biotech, GSK to cut malaria vaccine price by more than half by 2028

The collaboration, supported by Gavi and WHO, aims to protect at least 50 million more children in Africa from malaria by 2030

Global Health Drive: Bharat Biotech, GSK to Halve Malaria Vaccine Cost by 2028

Vaccine Breakthrough: Bharat Biotech and GSK to cut malaria vaccine price below $5 by 2028, aiding millions across Africa under Gavi initiative.

Bharat Biotech and GSK cut price of world's first malaria vaccine to under $5

Bharat Biotech and GSK announce price reduction for the world’s first malaria vaccine to under $5. This move aims to improve access and save thousands of children in malaria-endemic countries.

Bharat Biotech, GSK to supply world’s first malaria vaccine RTS,S to Gavi

GSK and Bharat Biotech collaborate to reduce malaria vaccine price, enhance production, and supply to Gavi by 2028.

GlaxoSmithKline Receives Rs. 3.36 Cr GST Demand Order

GlaxoSmithKline Receives Rs. 3.36 Cr GST Demand Order Mumbai-based pharmaceutical company GlaxoSmithKline received an order on 24th June 2025, from the Commissioner, CGST & CX, Appeals-II, Kolkata, regarding Disallowance of transitional credit (TRAN 1 & TRAN 2 credit) for FY 2017–18. The said authority has raised a total demand of Rs. 3,39,09,520 from the company. […]